- All sections
- C - Chemistrymetallurgy
- C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
- C12P 21/04 - Cyclic or bridged peptides or polypeptides, e.g. bacitracin
Patent holdings for IPC class C12P 21/04
Total number of patents in this class: 860
10-year publication summary
|
22
|
27
|
27
|
22
|
16
|
8
|
11
|
5
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4398 |
11 |
| Abbvie Inc. | 1847 |
11 |
| Novartis AG | 10350 |
8 |
| Ajinomoto Co., Inc. | 2281 |
8 |
| Bunge Oils, Inc. | 113 |
8 |
| Regeneron Pharmaceuticals, Inc. | 4591 |
8 |
| The University of Tokyo | 4320 |
8 |
| Genentech, Inc. | 4061 |
7 |
| California Institute of Technology | 4011 |
7 |
| Novozymes A/S | 3344 |
7 |
| CJ Cheiljedang Corporation | 3566 |
7 |
| Codexis, Inc. | 816 |
7 |
| Gevo, Inc. | 277 |
7 |
| The Regents of the University of California | 20506 |
6 |
| Allergan, Inc. | 2220 |
6 |
| President and Fellows of Harvard College | 6040 |
6 |
| Novartis Vaccines and Diagnostics, Inc. (a Delaware corporation) | 24 |
5 |
| Massachusetts Institute of Technology | 10196 |
5 |
| University of Florida Research Foundation, Inc. | 4140 |
5 |
| Biogen MA Inc. | 926 |
5 |
| Other owners | 718 |